164 related articles for article (PubMed ID: 23656242)
1. Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism.
Yamazaki S; Kanamoto A; Takayama T
Clin Exp Immunol; 2013 Aug; 173(2):173-8. PubMed ID: 23656242
[TBL] [Abstract][Full Text] [Related]
2. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
Timrott K; Beetz O; Oldhafer F; Klempnauer J; Vondran FWR; Jäger MD
PLoS One; 2020; 15(5):e0233497. PubMed ID: 32442182
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
4. Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for inducing chimerism.
Huang Y; Wu X; Tang S; Wu H; Nasri U; Qin Q; Song Q; Wang B; Tao H; Chong AS; Riggs AD; Zeng D
Am J Transplant; 2023 Aug; 23(8):1116-1129. PubMed ID: 37105316
[TBL] [Abstract][Full Text] [Related]
5. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
[TBL] [Abstract][Full Text] [Related]
6. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance.
Khan A; Tomita Y; Sykes M
Transplantation; 1996 Aug; 62(3):380-7. PubMed ID: 8779687
[TBL] [Abstract][Full Text] [Related]
7. Splenocytes can replace chimeric cells and maintain allograft tolerance.
Hayashi Y; Yamazaki S; Kanamoto A; Takayama T
Transplantation; 2007 Nov; 84(9):1168-73. PubMed ID: 17998873
[TBL] [Abstract][Full Text] [Related]
8. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
9. iNKT cell activation plus T-cell transfer establishes complete chimerism in a murine sublethal bone marrow transplant model.
Ishii R; Hirai T; Miyairi S; Omoto K; Okumi M; Ishii Y; Tanabe K
Am J Transplant; 2018 Feb; 18(2):328-340. PubMed ID: 28766890
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
Pierce GE
Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
[TBL] [Abstract][Full Text] [Related]
11. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
14. Facilitating cells as a venue to establish mixed chimerism and tolerance.
Jacquet EG; Schanie CL; Fugier-Vivier I; Willer SS; Ildstad ST
Pediatr Transplant; 2003 Oct; 7(5):348-57. PubMed ID: 14738294
[TBL] [Abstract][Full Text] [Related]
15. Partially MHC-matched donor CD8+ T cells are indispensable for switching to splenocytic chimerism.
Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Okada S; Kanamoto A; Takayama T
J Surg Res; 2012 Jun; 175(1):62-6. PubMed ID: 21470627
[TBL] [Abstract][Full Text] [Related]
16. Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.
Kanamoto A; Maki T
J Immunol; 2004 Feb; 172(3):1444-8. PubMed ID: 14734720
[TBL] [Abstract][Full Text] [Related]
17. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B-->A) to secondary recipients.
Wren SM; Hronakes ML; Ildstad ST
Transplantation; 1992 Dec; 54(6):1031-40. PubMed ID: 1465769
[TBL] [Abstract][Full Text] [Related]
18. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
19. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
20. Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation.
Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Kanamoto A; Okada S; Takayama T
J Surg Res; 2012 Nov; 178(1):133-8. PubMed ID: 22502904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]